Liman Huo

Shijiazhuang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Economic evaluation of newly approved cetuximab biosimilars for first-line treatment of RAS/BRAF wild-type metastatic colorectal cancer in China.

Economic evaluation of newly approved cetuximab biosimilars for first-line treatment of RAS/BRAF wild-type metastatic colorectal cancer in China.

Journal: Frontiers in oncology

Published: June 05, 2026

Cost-effectiveness of nivolumab plus ipilimumab versus lenvatinib or sorafenib for unresectable hepatocellular carcinoma in China: a modeling study with price threshold analysis.

Cost-effectiveness of nivolumab plus ipilimumab versus lenvatinib or sorafenib for unresectable hepatocellular carcinoma in China: a modeling study with price threshold analysis.

Journal: Frontiers in pharmacology

Published: April 20, 2026

Peripheral nervous system safety signals of antibody-drug conjugates: cross-database reproducibility and labeling gaps identified using FAERS, JADER, and CVARD.

Peripheral nervous system safety signals of antibody-drug conjugates: cross-database reproducibility and labeling gaps identified using FAERS, JADER, and CVARD.

Journal: Frontiers in pharmacology

Published: January 13, 2026

Cost-utility and price threshold analysis of sacituzumab tirumotecan versus single-agent chemotherapy for previously treated metastatic triple-negative breast cancer in China.

Cost-utility and price threshold analysis of sacituzumab tirumotecan versus single-agent chemotherapy for previously treated metastatic triple-negative breast cancer in China.

Journal: Frontiers in public health

Published: January 13, 2026

Synthesis and evaluation of Urolithins derivatives as anticancer agents for hepatocellular carcinoma: In vitro, molecular docking, and dynamics simulations.

Synthesis and evaluation of Urolithins derivatives as anticancer agents for hepatocellular carcinoma: In vitro, molecular docking, and dynamics simulations.

Journal: Bioorganic chemistry

Published: December 01, 2025

Cost-effectiveness of ramucirumab plus paclitaxel as maintenance therapy for patients with advanced HER2-negative gastric or gastroesophageal junction cancer.

Cost-effectiveness of ramucirumab plus paclitaxel as maintenance therapy for patients with advanced HER2-negative gastric or gastroesophageal junction cancer.

Journal: Frontiers in oncology

Published: September 26, 2025

Area-Selective Atomic Layer Deposition of AlOx at the Buried Interface for High-Performance Perovskite Solar Cells.

Area-Selective Atomic Layer Deposition of AlOx at the Buried Interface for High-Performance Perovskite Solar Cells.

Journal: Angewandte Chemie (International ed. in English)

Published: July 28, 2025

Tranexamic acid inhibits mitochondrial DNA release and reduces inflammatory response in an in vitro model of OGD/R-induced Caco-2 cell injury.

Tranexamic acid inhibits mitochondrial DNA release and reduces inflammatory response in an in vitro model of OGD/R-induced Caco-2 cell injury.

Journal: BMC pharmacology & toxicology

Published: July 28, 2025

Efficacy and safety of first-line targeted and immunotherapy for metastatic colorectal cancer: a network meta-analysis.

Efficacy and safety of first-line targeted and immunotherapy for metastatic colorectal cancer: a network meta-analysis.

Journal: Frontiers in immunology

Published: June 08, 2025

Adoptive cellular immunotherapy combined with chemotherapy versus chemotherapy alone in Chinese patients with metastatic colorectal cancer: a cost-effectiveness analysis to inform drug pricing.

Adoptive cellular immunotherapy combined with chemotherapy versus chemotherapy alone in Chinese patients with metastatic colorectal cancer: a cost-effectiveness analysis to inform drug pricing.

Journal: Frontiers in oncology

Published: March 09, 2025

Severe thyrotoxicosis induced by tislelizumab: a case report and literature review.

Severe thyrotoxicosis induced by tislelizumab: a case report and literature review.

Journal: Frontiers in oncology

Published: March 21, 2023

Norvancomycin plasma concentration monitoring in hemodialysis patients with end stage kidney disease: A retrospective cohort study.

Norvancomycin plasma concentration monitoring in hemodialysis patients with end stage kidney disease: A retrospective cohort study.

Journal: Biopharmaceutics & drug disposition

Published: February 01, 2023

Showing 1-12 of 12

Last Updated: 09/26/2026